SCHEMBL18901405

SCHEMBL18901405

COc1cccc(CNC(=O)c2ccc3c(c2)c(=O)[nH]c2ccccc23)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 8/20 0.63
MMP13 P45452 5/20 0.62
SMN1; SMN2 Q16637 1/20 0.57
LMNA P02545 1/20 0.56
HPGD P15428 1/20 0.56
MAPT P10636 2/20 0.55
IMPDH2 P12268 1/20 0.54
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
PRKACA P17612 1/20 0.53
GSK3A P49840 1/20 0.53
GSK3B P49841 1/20 0.53
PRKX P51817 1/20 0.53
PRKCQ Q04759 1/20 0.53
ROCK1 Q13464 1/20 0.53
CLK4 Q9HAZ1 1/20 0.53
KDM4E B2RXH2 1/20 0.53
MEN1 O00255 1/20 0.53
USP2 O75604 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17783413 0.88 ROCK2 (0.82) ROCK2MMP13CYP3A4CYP2D6CYP2C9
SCHEMBL18901302 0.84 ROCK2 (0.82) ROCK2MMP13CYP3A4CYP2D6CYP2C9
SCHEMBL7101052 0.80 MMP13 (0.61) ROCK2MMP13LMNAHPGDMAPT
SCHEMBL2463183 0.78 MMP13 (0.61) ROCK2MMP13SMN1; SMN2LMNAHPGD
SCHEMBL5332068 0.78 MMP13 (1.00) ROCK2MMP13SMN1; SMN2LMNAHPGD
SCHEMBL9416645 0.78 MMP13 (0.94) ROCK2MMP13SMN1; SMN2LMNAHPGD
SCHEMBL31061610 0.78 MMP13 (1.00) ROCK2MMP13SMN1; SMN2LMNAHPGD
SCHEMBL17783468 0.78 ROCK2 (1.00) ROCK2MMP13CYP3A4CYP2D6CYP2C9
SCHEMBL34468703 0.78 KDM4E (0.60) ROCK2MMP13SMN1; SMN2HPGDMAPT
SCHEMBL7134254 0.77 MMP13 (0.86) ROCK2MMP13SMN1; SMN2LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3016951-B1 TRICYCLIC PYRIDO-CARBOXAMIDE DERIVATIVES AS ROCK INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-05-31 EP disclosed